Compare FULT & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FULT | PRGO |
|---|---|---|
| Founded | 1882 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 1.8B |
| IPO Year | N/A | 1991 |
| Metric | FULT | PRGO |
|---|---|---|
| Price | $20.23 | $13.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $20.75 | ★ $22.00 |
| AVG Volume (30 Days) | 2.1M | ★ 4.8M |
| Earning Date | 01-20-2026 | 11-05-2025 |
| Dividend Yield | 3.76% | ★ 8.77% |
| EPS Growth | ★ 20.91 | N/A |
| EPS | ★ 1.91 | N/A |
| Revenue | $1,230,470,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.29 | N/A |
| P/E Ratio | $10.56 | ★ N/A |
| Revenue Growth | ★ 9.56 | N/A |
| 52 Week Low | $14.33 | $12.17 |
| 52 Week High | $21.40 | $30.93 |
| Indicator | FULT | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 70.07 | 41.18 |
| Support Level | $20.09 | $12.74 |
| Resistance Level | $20.77 | $13.63 |
| Average True Range (ATR) | 0.43 | 0.46 |
| MACD | 0.09 | 0.24 |
| Stochastic Oscillator | 78.40 | 51.62 |
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.